Category: Joint ventures/collaborations
-
Intel to Invest $100M in Automotive Electronics R&D
Intel Capital, the venture capital arm of semiconductor maker Intel Corporation in Santa Clara, California has established a $100 million fund for investments in equipment, software, and service developers in the automotive industry. The new fund was one of several programs in the automotive sector announced by Intel, including an automotive innovation/product development center, expanded…
-
Avanir, Concert in Licensing Deal for Neurological Drugs
The biopharmaceutical company Avanir Pharmaceuticals Inc. in Aliso Viejo, California and the biotechnology firm Concert Pharmaceuticals in Lexington, Massachusetts have agreed on a deal that licenses Concert’s drug-development technology to design treatments for neurological and psychiatric disorders. While the companies did not disclose financial details, the industry Web site Xconomy says the deal can provide…
-
Research Institute, XCOR Partner on Suborbital Test Flights
Southwest Research Institute (SwRI) in San Antonio says it will conduct suborbital space missions with SwRI payload specialist astronauts flying aboard one or two test missions in the XCOR Aerospace Lynx Mark I vehicle. The flights are expected to test capabilities of the Lynx vehicle with actual researchers and research experiments aboard. About one year…
-
Universal Vaccines Assessed for Widespread Flu Prevention
Researchers In the U.S. and the U.K. have developed a simulation model to assess the ability of universal vaccines — those that cover a number of disease variations — to prevent the spread of influenza. The team from Princeton University and Duke University, Imperial College London, National Institutes of Health, and Food and Drug Administration…
-
Biotech, GSK to Partner on Rare Inherited Cellular Diseases
Angiochem, a biotechnology company in Montreal, Canada says it will collaborate with the global pharmaceutical company GlaxoSmithKline on treatments for lysosomal storage diseases, a type of rare, inherited conditions causing cellular dysfunctions. Under the agreement, Angiochem will be eligible for at least $300 million in payments. Lysosomal storage diseases are a class of disorders caused…
-
Nanotech Fiber Material Converts Heat to Electricity
Researchers at Wake Forest University in Winston-Salem, North Carolina have developed a fiber-like material with the ability to convert heat, such as body heat, into electric power. The team, which includes researchers from universities in New Zealand and Korea, and the company NanoTechLabs Inc. in nearby Yadkinville, North Carolina published its findings online in the…
-
GE, Carbon Trust to Partner on Clean Tech Start-Up Support
General Electric and the U.K. environmental organization Carbon Trust will collaborate on backing start-up companies in Europe focusing on clean technologies. The partnership comes as the share of European investment in clean energy has declined over the past five years. During the first 18 months of the partnership, the Carbon Trust and GE will identify…
-
Bayer, Texas AgrilLife to Partner on New Wheat Varieties
Bayer CropScience in Monheim, Germany and Texas AgriLife Research in College Station will collaborate on developing improved types of wheat and taking them to market. Financial details of the deal were not disclosed. Researchers at the two organizations plan to develop wheat lines that offer drought and disease resistance which are important properties for wheat…
-
J&J, University to Partner on Spider Venom Therapy for Pain
Researchers at University of Queensland in Australia are collaborating with the U.S. pharmaceutical company Johnson & Johnson to develop components of spider venom as a potential treatment for pain. Johnson & Johnson’s Corporate Office of Science and Technology (COSAT) and other company units will provide funding to the university’s Institute for Molecular Bioscience for the…
-
Device Company, MIT Test Drug-Delivery Implanted Microchip
Scientists at medical technology developer MicroCHIPS in Walthan, Massachusetts and MIT reported the results of a successful human clinical trial of a programmable and wirelessly controlled implanted microchip to deliver drugs. The results appear online in the journal Science Translational Medicine (paid subscription required). The trial, the first successful test of this type of device,…